Abstract
289 - Safety and Disease Outcomes of Commercial CD19 CAR T-Cell Therapy in Patients with Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma: A Single Institution Experience
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
